Education
About Us
Working with TipRanks
Follow Us
Nirvana Life Sciences Inc (TSE:NIRV)
:NIRV
| Jun 23 | Jun 22 | Dec 20 | Dec 19 | |
|---|---|---|---|---|
| Income Statement | ||||
| Total Revenue | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Gross Profit | C$ 0.00 | C$ 0.00 | C$ 0.00 | C$ 0.00 |
| Operating Income | - | C$ -859.12K | C$ -314.24K | C$ -74.53K |
| EBITDA | - | C$ 3.40M | C$ -314.24K | C$ -74.53K |
| Net Income | - | C$ -5.65M | C$ -314.24K | C$ 13.31K |
| Balance Sheet | ||||
| Cash & Short-Term Investments | C$ 12.49K | C$ 35.77K | C$ 2.25K | C$ 682.00 |
| Total Assets | C$ 68.57K | C$ 486.58K | C$ 2.36K | C$ 4.38K |
| Total Debt | C$ 58.40K | C$ 0.00 | C$ 26.51K | C$ 323.45K |
| Net Debt | C$ 45.91K | C$ -35.77K | C$ 24.26K | C$ 322.77K |
| Total Liabilities | C$ 1.01M | C$ 648.17K | C$ 531.83K | C$ 745.29K |
| Stockholders' Equity | C$ -936.35K | C$ -162.31K | C$ -529.47K | C$ -740.92K |
| Cash Flow | ||||
| Free Cash Flow | C$ -333.21K | C$ -490.19K | - | C$ -41.85K |
| Operating Cash Flow | C$ -333.21K | C$ -490.19K | C$ -20.64K | C$ -41.85K |
| Investing Cash Flow | C$ 0.00 | C$ -100.84K | - | C$ 0.00 |
| Financing Cash Flow | C$ 309.93K | C$ 2.27K | C$ 22.21K | C$ 3.45K |
Nirvana Life Sciences Inc Forecast EPS vs Actual EPS
Currently, no data available
Please return soon. This page is being updated.